Literature DB >> 7431164

Endocrine and neurologic outcome in childhood craniopharyngioma: Review of effect of treatment in 42 patients.

M J Thomsett, F A Conte, S L Kaplan, M M Grumbach.   

Abstract

Forty-two cases of craniopharyngioma in children reviewed. Only 9.5% had sought medical attention because of symptoms suggesting hormonal deficit; however, growth retardation was present in 53% and growth hormone deficiency was documented in 72% before treatment. Multiple hypothalamic-pituitary hormone deficiencies were present in all patients after treatment. Eleven percent had normal skull radiographs at presentation; pneumonencephalograms and computed tomographic brain scans were abnormal on every occasion on which they were performed. Recurrence and mortality rates as well as the neurologic outcome of survivors were similar in children treated by radical excision and those treated by limited excision plus radiotherapy. The neurologic prognosis was poorest in those children who had limited excision or drainage without radiotherapy. Additional hypothalamic-pituitary dysfunction following treatment was less common in children who had limited excision plus radiotherapy than in children who had either limited excision or attempted total removal. Unless gross total tumor excision can be readily achieved, limited excision by transsphenoidal microsurgery or craniotomy plus radiotherapy appears to be the treatment of choice for craniopharyngioma in childhood.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7431164     DOI: 10.1016/s0022-3476(80)80254-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  25 in total

1.  Headache and failure to thrive.

Authors:  Chantelle Barnard; Jeremy N Friedman
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

2.  Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.

Authors:  M Caldarelli; L Massimi; G Tamburrini; M Cappa; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2005-07-02       Impact factor: 1.475

Review 3.  Postoperative diabetes insipidus.

Authors:  J Seckl; D Dunger
Journal:  BMJ       Date:  1989-01-07

4.  Craniopharyngioma: history.

Authors:  Garni Barkhoudarian; Edward R Laws
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

Review 5.  Endocrine manifestations of craniopharyngioma.

Authors:  Isil Halac; Donald Zimmerman
Journal:  Childs Nerv Syst       Date:  2005-07-27       Impact factor: 1.475

6.  Water and sodium disorders following surgical excision of pituitary region tumours.

Authors:  W S Poon; Y I Lolin; T F Yeung; C P Yip; K Y Goh; M K Lam; C Cockram
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Stereotactic radiotherapy using Novalis for craniopharyngioma adjacent to optic pathways.

Authors:  Chisa Hashizume; Yoshimasa Mori; Tatsuya Kobayashi; Yuta Shibamoto; Aiko Nagai; Naoki Hayashi
Journal:  J Neurooncol       Date:  2010-04-27       Impact factor: 4.130

8.  Long-term follow-up of children with craniopharyngioma.

Authors:  N Stahnke; G Grubel; I Lagenstein; R P Willig
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

9.  Transnasal surgery in the treatment of craniopharyngiomas.

Authors:  A König; D K Lüdecke; H D Herrmann
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

10.  Endocrine function, morbidity, and mortality after surgery for craniopharyngioma.

Authors:  K R Lyen; D B Grant
Journal:  Arch Dis Child       Date:  1982-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.